These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23037649)

  • 1. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
    Karaiskos D; Tzavellas E; Spengos K; Vassilopoulou S; Paparrigopoulos T
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):349-53. PubMed ID: 23037649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial.
    Yan N; Hu S
    BMC Psychiatry; 2024 May; 24(1):365. PubMed ID: 38750479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
    Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of new antidepressants: focus on duloxetine and escitalopram.
    Huffman JC; Perlis RH
    Harv Rev Psychiatry; 2003; 11(1):30-6. PubMed ID: 12866739
    [No Abstract]   [Full Text] [Related]  

  • 6. [Impact of duloxetine on depression and anxiety in patients with ankylosing spondylitis: a case-control study].
    Li Y; Zhang SL; Zhu J; DU XN; Huang ZF; Huang F
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):966-9. PubMed ID: 23886255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.
    Wu WY; Wang G; Ball SG; Desaiah D; Ang QQ
    Chin Med J (Engl); 2011 Oct; 124(20):3260-8. PubMed ID: 22088518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.
    Fava M; Martinez JM; Greist J; Marangell LB; Brown E; Chen L; Wohlreich MM
    Ann Clin Psychiatry; 2007; 19(3):187-95. PubMed ID: 17729021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic effects of duloxetine on post-stroke depression symptoms: an open single-blind trial.
    Zhang LS; Hu XY; Yao LY; Geng Y; Wei LL; Zhang JH; Chen W
    Eur Neurol; 2013; 69(6):336-43. PubMed ID: 23549225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
    Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
    Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression treatment selectively modifies arterial stiffness in older participants.
    Scuteri A; Modestino A; Fedullo F; Assisi AP; Gianni W
    J Gerontol A Biol Sci Med Sci; 2013 Jun; 68(6):719-25. PubMed ID: 23160364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
    Bould H; Wiles N; Potokar J; Cowen P; Nutt DJ; Peters TJ; Lewis G
    J Psychopharmacol; 2012 May; 26(5):663-9. PubMed ID: 22223618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sertraline in the treatment and prevention of poststroke depression: A meta-analysis.
    Feng R; Wang P; Gao C; Yang J; Chen Z; Yang Y; Jiao J; Li M; Fu B; Li L; Zhang Z; Wang S
    Medicine (Baltimore); 2018 Dec; 97(49):e13453. PubMed ID: 30544429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant therapy in post-stroke depression.
    Starkstein SE; Mizrahi R; Power BD
    Expert Opin Pharmacother; 2008 Jun; 9(8):1291-8. PubMed ID: 18473704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine for the treatment of mood disorder in cancer patients: a 12-week case-control clinical trial.
    Torta R; Leombruni P; Borio R; Castelli L
    Hum Psychopharmacol; 2011; 26(4-5):291-9. PubMed ID: 21751250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.
    Rampello L; Alvano A; Chiechio S; Malaguarnera M; Raffaele R; Vecchio I; Nicoletti F
    Neuropsychobiology; 2004; 50(4):322-8. PubMed ID: 15539864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.
    Fornaro M; Martino M; Mattei C; Prestia D; Vinciguerra V; De Berardis D; De Pasquale C; Iasevoli F; Mungo S; Fornaro P
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1269-78. PubMed ID: 24842649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.